Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model

Aim: Prospective studies support the clinical impact of pharmacogenomics (PGx)-guided prescribing to reduce severe and potentially fatal adverse effects. Drug-gene interactions (DGIs) preventing potential drug-related deaths have been categorized as “essential” by the Dutch Pharmacogenetics Working...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Wouden, Cathelijne H., Marck, Heiralde, Guchelaar, Henk-Jan, Swen, Jesse J., van den Hout, Wilbert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477094/
https://www.ncbi.nlm.nih.gov/pubmed/36120299
http://dx.doi.org/10.3389/fphar.2022.918493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477094/
https://www.ncbi.nlm.nih.gov/pubmed/36120299
http://dx.doi.org/10.3389/fphar.2022.918493

Ejemplares similares